Correlation Between Hexo Corp and Aquestive Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hexo Corp and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hexo Corp and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hexo Corp and Aquestive Therapeutics, you can compare the effects of market volatilities on Hexo Corp and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hexo Corp with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hexo Corp and Aquestive Therapeutics.

Diversification Opportunities for Hexo Corp and Aquestive Therapeutics

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Hexo and Aquestive is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Hexo Corp and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and Hexo Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hexo Corp are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of Hexo Corp i.e., Hexo Corp and Aquestive Therapeutics go up and down completely randomly.

Pair Corralation between Hexo Corp and Aquestive Therapeutics

Given the investment horizon of 90 days Hexo Corp is expected to under-perform the Aquestive Therapeutics. In addition to that, Hexo Corp is 1.22 times more volatile than Aquestive Therapeutics. It trades about 0.0 of its total potential returns per unit of risk. Aquestive Therapeutics is currently generating about 0.08 per unit of volatility. If you would invest  86.00  in Aquestive Therapeutics on September 14, 2024 and sell it today you would earn a total of  276.00  from holding Aquestive Therapeutics or generate 320.93% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy25.66%
ValuesDaily Returns

Hexo Corp  vs.  Aquestive Therapeutics

 Performance 
       Timeline  
Hexo Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hexo Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Hexo Corp is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Aquestive Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aquestive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Hexo Corp and Aquestive Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hexo Corp and Aquestive Therapeutics

The main advantage of trading using opposite Hexo Corp and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hexo Corp position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.
The idea behind Hexo Corp and Aquestive Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals